NF1 and melanoma: Given that Calpain inhibitor I expression leads to increased NF1 stability and RAS inhibition and the strong contribution of the RAS pathway to promoting tumorigenesis [47], we reasoned that NF1 and CAPN1 expression levels may affect melanoma patient survival.